anticorps 2310036D22Rik, anticorps 5830455K21Rik, anticorps 6430519M21Rik, anticorps AI428776, anticorps AI661344, anticorps LRRGT00101, anticorps MGC81788, anticorps tmem106b, anticorps zgc:114147, anticorps zgc:64013, anticorps transmembrane protein 106B, anticorps transmembrane protein 106B S homeolog, anticorps transmembrane protein 106Bb, anticorps transmembrane protein 106b, anticorps transmembrane protein 106Ba, anticorps TMEM106B, anticorps Tmem106b, anticorps tmem106b.S, anticorps tmem106b, anticorps tmem106bb, anticorps Tsp_02056, anticorps Tsp_01553, anticorps t106b, anticorps tmem106ba
Sujet
Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.Synonyms: Transmembrane protein 106B